FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Health Outcomes with Geriatric-Specific Cancer Rehabilitation
New Innovations in Elderly Healthcare: Latest PBAC Outcomes
A Comparative Study on PRO Symptom Monitoring Approaches
Enhancing Patient Care in Oncology through Remote Patient Monitoring
A Value Framework for Next-Generation Sequencing in Europe: Access to Precisi...
Physician-Hospital Integration Impact on Healthcare Quality and Costs
Addressing the Challenges of Value Attribution in Combination Therapies
Extension of BowelScreen to Ages 50-54: A Cost-Effectiveness Analysis
Disparities in HPV Vaccination by Health Care Facility Type
HPV Vaccination Coverage in Japan: Challenges and Future Directions
How Socioeconomic Status Influences Lung Cancer Screening and Prognosis Over ...